Stannous Fluoride (Compound)

Synonyms:Tin(II) fluoride, STANNOUS FLUORIDE, 7783-47-3, Tin difluoride, Fluoristan, difluorotin, Tin bifluoride, Difluorostannylene, Tin Fluoride (SnF2), SnF2, Stannous fluoride (USP), Stannous fluoride [USP], Easygel, Stancare, Stanide, Crest, Stop, Omnii-Gel, Gel-Kam, Iradicar SnF2, Iradicav SnF2, King's Gel-Tin, Cap-Tin Mouthrinse, Stop Home Treatment, Iradicar Stannous Fluoride, Stannous fluoride (SnF2), tin ii fluoride, HSDB 783, tin(+2)fluoride, stannous difluoride, Gingimed (TN), EINECS 231-999-3, Oral-B Rinsing solution, concentrate, MFCD00042540, F2Sn, TIN (II) FLUORIDE, Tin(II) fluoride, 99%, DTXSID6064822, Tin (II) Fluoride, -4 Mesh, CHEBI:135933, 8584AF, DB11092, FT-0695303, D05919, A929354, Q204962, Samarium Barium Copper Oxide (SBCO) Sputtering Targets, 4-chloro-2-pyridinemethanamine;(4-chloropyridin-2-yl)methanamine
Pubchem:PUBCHEM:24550
Id:157ec7fa-6b05-512b-a54a-a22d9b7a2d01
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Stannous Fluoride's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Stannous Fluoride.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Stannous Fluoride.

Results found

Linked to

 

Label

Description

 

Collection

Metadatata for stannous fluoride

Collection

DrugPage Collection: (DrugCentralID:04273; PubChem_CID:24550, FILE=drugcentral_drug_04273.json)

Knowledge Graph Assertion

A Knowledge Graph Assertion from IDG


  • Collection

    DrugPage Collection: (DrugCentralID:04273; PubChem_CID:24550, FILE=drugcentral_drug_04273.json)


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.